-+ 0.00%
-+ 0.00%
-+ 0.00%

Nektar Therapeutics Announces Topline Results from Phase 2b REZOLVE-AD Trial of Rezpegaldesleukin in Atopic Dermatitis

Reuters·02/09/2026 21:16:04

Please log in to view news